-
Posted by
Two Blokes May 20, 2025 -
Filed in
Stock
-
5 views
Deutsche Bank has reiterated its 'buy' rating on Creo Medical Group PLC (AIM:CREO) with a price target of 40p following the company's full-year results on Monday. The target implies a near fourfold increase from the current share price of just over 10p.
